Mixed T/myeloid phenotype acute leukemia with rare variants of IDH1 and CEBPA
Authors:
- 16 April 2013
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 54 (11) , 2568-2570
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classificationHaematologica, 2012
- ETV6 mutations in early immature human T cell leukemiasJournal of Experimental Medicine, 2011
- Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemiaBlood, 2011
- Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate productionOncogene, 2011
- Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classificationBlood, 2011
- DNMT3AMutations in Acute Myeloid LeukemiaNew England Journal of Medicine, 2010
- Mixed-phenotype acute leukemia: historical overview and a new definitionLeukemia, 2010
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001